Past clinical and experimental observations suggest that certain skin antigens may be involved in focusing immune reactions to cutaneous sites. The major objective of the proposed studies is to examine the expression and distribution of cellular and extracellular components located in the region of the epidermal basal layer that are recognized by antibodies from serum or skin of LE patients with widespread skin disease and photosensitivity. The effect of ultraviolet light, cellular proliferation, and/or differentiation on Ro/SSA and La/SSB antigen expression will be examined using monospecific lupus and rabbit sera and monoclonal antibodies. Epidermal basement membrane zone(EBMZ) antibodies from LE patients and rabbits immunized with EBMZ material will also be used to identify and isolate the corresponding antigen. Both in vivo and in vitro systems will be used to study the distribution and expression of these antigens using immunofluorescence, immunoelectron microscopic, immunoprecipitation, gel filtration and autoradiographic techniques. Particular attention will be paid to the influence of cell cycle, cellular proliferation, differentiation and ultraviolet light on antigen expression and location. A skin organ culture system will be used to examine the mechanism(s) involved in ultraviolet light induced inflammatory mediator release and the effect of antibodies to these antigens on this process. Findings from these studies may lead to a better understanding of the mechanism(s) involved in localizing the cutaneous injury in LE to the basal layer. The findings from these studies may also provide insight into factors that are responsible for aggravating or initiating cutaneous injury in LE. This information could, in turn, lead to better methods for controlling the cutaneous injury which is such a common feature of this disorder.

Project Start
1979-05-01
Project End
1986-12-31
Budget Start
1986-01-01
Budget End
1986-12-31
Support Year
10
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Sontheimer, Richard D (2005) Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun Rev 4:253-63
Sontheimer, Richard D; Racila, Emil; Racila, Doina M (2005) C1q: its functions within the innate and adaptive immune responses and its role in lupus autoimmunity. J Invest Dermatol 125:14-23
Sontheimer, Richard D (2004) The management of dermatomyositis: current treatment options. Expert Opin Pharmacother 5:1083-99
Ting, W; Stone, M S; Racila, D et al. (2004) Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus and the spectrum of the acute syndrome of apoptotic pan-epidermolysis (ASAP): a case report, concept review and proposal for new classification of lupus erythematosus vesiculobullous skin Lupus 13:941-50
Wu, Qiang; Fu, Yang-Xin; Sontheimer, Richard D (2004) Blockade of lymphotoxin signaling inhibits the clinical expression of murine graft-versus-host skin disease. J Immunol 172:1630-6
Geraminejad, Pedram; DeBloom 2nd, James R; Walling, Hobart W et al. (2004) Alpha-1-antitrypsin associated panniculitis: the MS variant. J Am Acad Dermatol 51:645-55
Sontheimer, Richard D (2004) Skin manifestations of systemic autoimmune connective tissue disease: diagnostics and therapeutics. Best Pract Res Clin Rheumatol 18:429-62
Racila, D M; Sontheimer, C J; Sheffield, A et al. (2003) Homozygous single nucleotide polymorphism of the complement C1QA gene is associated with decreased levels of C1q in patients with subacute cutaneous lupus erythematosus. Lupus 12:124-32
Sontheimer, Richard D (2002) Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin 20:387-408
Sontheimer, Richard D (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46:626-36

Showing the most recent 10 out of 53 publications